Evidence map›Paper›PMID 35516792›Full record

ArticleRespiratory medicine case reports2022

Common Presentation of Uncommon Disease: Inflammatory myofibroblastic tumor of the lung, case report.

Safwat Eldaabossi, Lotfi Maghmoul, Elsaid Lotfy, Ahmad Antar, Yasser Elghoneimy, Hameed Aljawad, Ayman Ghoneim

Open access · goldAbstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Inflammatory Myofibroblastic Tumor of the Lung: A Rare Find in an Elderly Female.Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Safwat EldaabossiPulmonology Consultant, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia.
Lotfi MaghmoulPulmonology Consultant, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia.
Elsaid LotfyRadiology Consultant, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia.
Ahmad AntarHematology-Oncology Consultant, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia.
Yasser ElghoneimyCardiothoracic Consultant, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia.
Hameed AljawadPathology Consultant Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia.
Ayman GhoneimCardiothoracic Consultant, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia.
Saad Specialist Hospital · SAAl-Azhar University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammatory myofibroblastic tumor (IMT) of the lung is a rare lung tumor, accounting for 0.7% of all lung tumors. They are usually benign, but can invade surrounding structures, undergo malignant transformation, recur, or even metastasize. Case report: We report a 44-year-old adult diabetic male from Saudi Arabia who had been suffering from cough with severe sputum and left shoulder pain for 2 weeks. Chest radiography (X-ray and computed tomography (CT)) revealed the presence of a mass lesion in the left lower upper lobe with central cavitation. The diagnosis of inflammatory myofibroblast lung tumor was confirmed by histological and immunohistochemical examination of the CT guided lung biopsy. The patient was successfully treated with surgical resection of the tumor by left limited thoracotomy with safety margin, and IMT was also documented. Conclusion: A high degree of suspicion of a solitary pulmonary mass is required for diagnosis and management of an inflammatory myofibroblastic lung tumor. The clinical and radiologic presentation of an inflammatory myofibroblastic tumor is nonspecific and the diagnosis is rarely made before surgical biopsy. Histologic and immunohistochemical examination is usually required to confirm the diagnosis and prevent recurrence.

Indexed as

Inflammatory myofibroblastic tumorLung cavityLung mass

Identifiers

PMID35516792
PMCPMC9065430
OpenAlexW4226434955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.